FiREapps has offices in ArizonaCalifornia Florida North Carolina and OregonSolutions Enable Tunable White Lighting with Highestlumen LEDsSAN JOSE CalifClausen himself was probably influenced by QuinnGM was the only domestic brand with Most Delightful segment leadersNASDAQ JDAS today announced that Market BasketStores IncInvestor RelationsThe Berlin GroupLawrence Delaney JrorEntech Solar Investor RelationsChris Witty Copyright Business Wire 2009Leigh said I am excited to join Motricityand its leadership team2 and strikeouts 261 to 144 a lower BAA More than 10 million people visit StatelessSystems websites each monthThis novel system takes cell-free protein synthesis to an entirely newand advanced level, and I look forward to helping the company realize thecommercial potential of this technology." The company also noted that Sutro Biopharma had recently relocated its corporateheadquarters and research and development operations from Menlo Park to anexpanded facility in South San Francisco, CA. The new research facility includesboth laboratory space and a pilot scale facility to support the companysresearch and development programs William J Newell BiographyWilliam J. Newell has been a senior executive within the biotechnology industryfor more than ten years. He served as the President of Aerovance, Inc., aclinical stage biotechnology company developing therapeutics for respiratory anddermatologic diseases. He was also the Chief Business Officer of QLT, Inc., apublicly traded biotechnology company that develops and commercializes oculartherapeutics Prior to that, Mr Newell was employed by Axys Pharmaceuticals,Inc. (and subsequently its successor company Celera Genomics) as a seniorexecutive, ultimately serving as Senior Vice President, Corporate and BusinessDevelopment Prior to joining Axys Mr. 
Newell was a partner in the law firm ofBingham McCutchen LLP About Sutro Biopharma, Inc.Sutro Biopharma, Inc. is a biopharmaceutical company that uses its patented OCFS(Open Cell-Free Synthesis) technology to develop novel biomedicines for thetreatment of human disease. This commercially scalable technology overcomes manyof the limitations frequently associated with mammalian, yeast and bacterialsystems. The companys technology is applicable to challenging to make proteins,antibody derivatives and other sophisticated, non-native proteins fortherapeutic use. The companys technology can also be utilized to provide novelfunctionalities that will improve the therapeutic profile of biopharmaceuticalproducts.
The company was established in 2004 and hasreceived commitments for over $23 M in funding since its inception. For moreinformation on Sutro Biopharma, please visit our website at http:// Sutro BiopharmaceuticalsWilliam Newell, CEO, 650-392-8412 ext. orKureczka/Martin AssociatesJoan Kureczka, 415-821-2413 (Media)Copyright Business Wire 2009. QuantiSenses business intelligence solution is a packaged, retail-specificapplication built on MicroStrategys industry-leading data warehouse andtechnology platform. The applications role-based dashboards enable exceptionreporting with easy drill-down capability, and the signature QuantiSensePlaybooks guide users to specific action based on recurring scenarios each keyretail role faces every day. The new QuantiSense Extensions, delivered by the companys Professional Servicesteam, are designed to help retailers continue the momentum of their initialQuantiSense implementation and expand into new areas of retail insight.Available for the areas of marketing, direct-to-consumer, cross-channelanalysis, store operations, vendor profitability, and clustering, these expandedcapabilities combine field-proven code with the expertise of the QuantiSenseProfessional Services team to deliver retailers a competitive advantage derivedfrom decades of real-world retail experience working with the worlds leadingretailers. Marketing: Customer and Promotional AnalyticsRetailers know how important it is to understand customers from every angle andanalyze key customer metrics.
